Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03634215Completed

Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma

Role: lead

NCT03286985Completed

The Prevalence and Incidence of DVT in General ICU

Role: lead

NCT04529187Phase 4Completed

Effect of Midazolam and Dexmedetomidine on Heart Function - A Randomized MRI-based Study.

Role: lead

NCT03924583Unknown

Duplex Ultrasonography Performed by Nurses

Role: lead

NCT02619539Completed

Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)

Role: lead

All 5 trials loaded